Moses S. Elisaf - Search Results

Year	Number of Results
2002	9
2003	10
2004	8
2005	20
2006	12
2007	11
2008	15
2009	5
2010	20
2011	19
2012	24
2013	26
2014	17
2015	13
2016	16
2017	19
2018	8
2019	10
2020	4
2022	1

1

Evaluation and treatment of hypernatremia: a practical guide for physicians.

Liamis G, Filippatos TD, Elisaf MS. Liamis G, et al. Among authors: elisaf ms. Postgrad Med. 2016;128(3):299-306. doi: 10.1080/00325481.2016.1147322. Epub 2016 Feb 23. Postgrad Med. 2016. PMID: 26813151 Review.

2

Hyponatremia in the elderly: challenges and solutions.

Filippatos TD, Makri A, Elisaf MS, Liamis G. Filippatos TD, et al. Among authors: elisaf ms. Clin Interv Aging. 2017 Nov 14;12:1957-1965. doi: 10.2147/CIA.S138535. eCollection 2017. Clin Interv Aging. 2017. PMID: 29180859 Free PMC article. Review.

3

Treatment of Hypertension in Chronic Kidney Disease.

Kalaitzidis RG, Elisaf MS. Kalaitzidis RG, et al. Among authors: elisaf ms. Curr Hypertens Rep. 2018 Jun 11;20(8):64. doi: 10.1007/s11906-018-0864-0. Curr Hypertens Rep. 2018. PMID: 29892833 Review.

4

Adverse Effects of GLP-1 Receptor Agonists.

Filippatos TD, Panagiotopoulou TV, Elisaf MS. Filippatos TD, et al. Among authors: elisaf ms. Rev Diabet Stud. 2014 Fall-Winter;11(3-4):202-30. doi: 10.1900/RDS.2014.11.202. Epub 2015 Feb 10. Rev Diabet Stud. 2014. PMID: 26177483 Free PMC article. Review.

5

Orlistat-associated adverse effects and drug interactions: a critical review.

Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS. Filippatos TD, et al. Among authors: elisaf ms. Drug Saf. 2008;31(1):53-65. doi: 10.2165/00002018-200831010-00005. Drug Saf. 2008. PMID: 18095746 Review.

6

SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses.

Filippatos TD, Liontos A, Papakitsou I, Elisaf MS. Filippatos TD, et al. Among authors: elisaf ms. Postgrad Med. 2019 Mar;131(2):82-88. doi: 10.1080/00325481.2019.1581971. Postgrad Med. 2019. PMID: 30757937 Review.

7

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Rizos EC, et al. Among authors: elisaf ms. JAMA. 2012 Sep 12;308(10):1024-33. doi: 10.1001/2012.jama.11374. JAMA. 2012. PMID: 22968891 Review.

8

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study.

Tromp TR, Hartgers ML, Hovingh GK, Vallejo-Vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-Shiba M, Blom DJ, Raal FJ, Cuchel M; Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Tromp TR, et al. Lancet. 2022 Feb 19;399(10326):719-728. doi: 10.1016/S0140-6736(21)02001-8. Epub 2022 Jan 28. Lancet. 2022. PMID: 35101175

9

Metformin and cancer.

Rizos CV, Elisaf MS. Rizos CV, et al. Among authors: elisaf ms. Eur J Pharmacol. 2013 Apr 5;705(1-3):96-108. doi: 10.1016/j.ejphar.2013.02.038. Epub 2013 Mar 13. Eur J Pharmacol. 2013. PMID: 23499688 Review.

10

SGLT2 inhibitors: are they safe?

Filippas-Ntekouan S, Filippatos TD, Elisaf MS. Filippas-Ntekouan S, et al. Among authors: elisaf ms. Postgrad Med. 2018 Jan;130(1):72-82. doi: 10.1080/00325481.2018.1394152. Epub 2017 Oct 27. Postgrad Med. 2018. PMID: 29039237 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results